Show simple item record

dc.contributor.authorMolina, Ricardo 
dc.contributor.authorGhosh, Debashis
dc.contributor.authorCarrillo, Eugenia 
dc.contributor.authorMonnerat, Séverine
dc.contributor.authorBern, Caryn
dc.contributor.authorMondal, Dinesh
dc.contributor.authorAlvar, Jorge
dc.date.accessioned2022-04-07T20:06:04Z
dc.date.available2022-04-07T20:06:04Z
dc.date.issued2017-07-01
dc.identifier.citationClin Infect Dis. 2017;65(1):150-153.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/13961
dc.description.abstractWe compared xenodiagnosis with quantitative polymerase chain reaction in skin biopsies from 3 patients with maculopapular or nodular post-kala-azar dermal leishmaniasis (PKDL). All patients infected sand flies. Parasite loads in skin varied from 1428 to 63 058 parasites per microgram. PKDL detection and treatment are important missing components of the kala-azar elimination program.es_ES
dc.description.sponsorshipThis work was supported by the World Health Organization Special Programme for Research and Training in Tropical Diseases, Switzerland; Spanish Foundation for lnternational Cooperation, Health and Social Affairs; and icddr,b core donors.es_ES
dc.language.isoenges_ES
dc.publisherOxford University Press es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectControles_ES
dc.subjectLeishmaniasises_ES
dc.subjectPost–kala-azar dermal leishmaniasises_ES
dc.subjectXenodiagnosises_ES
dc.subject.meshLeishmania donovani es_ES
dc.subject.meshLeishmaniasis, Visceral es_ES
dc.subject.meshAdult es_ES
dc.subject.meshAnimals es_ES
dc.subject.meshDNA, Protozoan es_ES
dc.subject.meshFemale es_ES
dc.subject.meshHumans es_ES
dc.subject.meshIndia es_ES
dc.subject.meshMale es_ES
dc.subject.meshPolymerase Chain Reaction es_ES
dc.subject.meshPsychodidae es_ES
dc.subject.meshSkin es_ES
dc.subject.meshXenodiagnosis es_ES
dc.subject.meshYoung Adult es_ES
dc.titleInfectivity of Post-Kala-azar Dermal Leishmaniasis Patients to Sand Flies: Revisiting a Proof of Concept in the Context of the Kala-azar Elimination Program in the Indian Subcontinentes_ES
dc.typejournal articlees_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.identifier.pubmedID28520851es_ES
dc.format.volume65es_ES
dc.format.number1es_ES
dc.format.page150-153es_ES
dc.identifier.doi10.1093/cid/cix245es_ES
dc.contributor.funderWorld Health Organization (WHO/OMS) es_ES
dc.contributor.funderFundación CSAI (Salud, Infancia y Bienestar Social) es_ES
dc.contributor.funderInternational Centre for Diarrhoeal Disease Research, Bangladesh (India) es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1537-6591es_ES
dc.relation.publisherversionhttps://doi.org/10.1093/cid/cix245es_ES
dc.identifier.journalClinical Infectious Diseaseses_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
This item is licensed under a: Attribution-NonCommercial-NoDerivatives 4.0 Internacional